BioSpace News Archive

The study is being conducted under the leadership of Professor Yaron Dagan, head of the Sleep Medicine Institute at Assuta, and Principal Investigator, Dr. Lilach Kemer.

Three years ago, the U.S. Food and Drug Administration announced the most comprehensive reform to the Nutrition Facts label since its introduction in 1993.

With the help of philanthropic support for regenerative medicine and biomedical research, Dr. Robin Robinson, Ph.D., the first director of the Biomedical Advanced Research and Development Authority (BARDA) and former deputy Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS), was named a Fellow with the Thought Leadership & Innovation Foundation (TLI)

An estimated 7 million Americans have scoliosis*—that’s why Luke Stikeleather, National Scoliosis Center (NCS) Founder and President says:

In a life-saving leap for THE BIG ASK: THE BIG GIVE (BABG) platform, designed to increase kidney transplantation and living donation, the National Kidney Foundation (NKF) has expanded its BABG trainings to 15 additional markets across the country, thanks to a new partnership with the Fresenius Medical Care Foundation (FMCF).

Specialized driving instructors stress life skill development, parent-supervised practice, and individualized training to enhance learning and independence

The corporate presentation at the JMP Securities Life Sciences Conference will be available live on Vanda’s corporate website, where it also will be archived for 30 days.

A new collaboration between the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, and emergency technology company, RapidSOS, will help solve this issue by teaming up to promote a voluntary registry for citizens to share data with 911 and first responders

Company preparing to introduce an advanced continuous patient monitoring solution allowing for cost-effective management of patients throughout the care continuum

Technavio’s latest market research report on the global primary biliary cholangitis therapeutics market predicts the market to witness a CAGR of close to 10% during the forecast period.